Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
'Time for preparation, not celebration': Senior WHO official warns coronavirus is not defeated and Europe must brace for a deadly second wave this winter.
https://www.dailymail.co.uk/news/article-8359833/WHO-official-warns-coronavirus-not-defeated-Europe-brace-deadly-second-wave.html
https://polaris.brighterir.com/public/genedrive/news/rns/story/wv879px/export
Might have been posted before in which case I apologise. Dated 12th March 2020, Liverpool School of Tropical Medicine news release:
'Researchers at LSTM are working to develop and evaluate new diagnostic tests for the novel coronavirus COVID-19 that can be carried out in close to community settings and suitable for implementation in low-middle income countries.'
'The team from LSTM, who are all members of NIHR Health Protection Research Unit in Emerging and Zoonotic Infections are working closely with industry contacts and will develop two point of care diagnostic assays that are suitable for use at A&E and outpatient health services.'
The first test is a development programme with Mologic and the second with GDR.
'The second test is being developed with industrial partners Genedrive, with whom we have submitted grant applications based upon prototype tests designed at LSTM and transferred to Genedrive’s portable PCR device. This test may help diagnose individuals outside of central referral systems, as even in Europe we cannot keep up with the huge demand for diagnosis tests."
https://www.lstmed.ac.uk/news-events/news/lstm-researchers-work-on-new-diagnostics-for-covid-19
Nice mention on Proactive Inv. along side Roche:
'Other companies are focusing on new kinds of diagnostic equipment such as Genedrive PLC (LON:GDR), which is developing a Covid-19 test to deliver results quickly in close proximity to patients, rather than needing to send samples to labs.'
https://www.proactiveinvestors.co.uk/companies/news/919586/uk-in-talks-to-buy-roches-covid-19-antibody-tests-following-us-eu-lead-919586.html
Apologies:
'Our Genedrive® 96 SARS-CoV-2 Kit is manufactured with a proprietary process that converts bulk PCR master mix into individual solid test beads. Each bead is an individual test. Mesmerising to watch these pour out in their thousands....'
The Company has granted to Peel Hunt and finnCap the Broker Option to raise up to approximately £1 million through the issue of up to 1,250,000 Broker Option Shares at the Placing Price. The Broker Option is designed to enable smaller shareholders in the Company and other retail and institutional investors to participate in the Fundraising.
The devil is in the detail of the RNS:
The Broker Option may be exercised by Peel Hunt and finnCap between 5 May 2020 and 5.00 p.m. on 11 May 2020 and, if exercised in full, shall require the Company to issue up to 1,250,000 Broker Option Shares. The exercise of the Broker Option shall be at the discretion of Peel Hunt and finnCap (with the agreement of the Company) and Peel Hunt and finnCap are under no obligation to exercise the Broker Option.
https://polaris.brighterir.com/public/genedrive/news/rns/story/rn17vkx
On linkedin now as well.....
https://www.linkedin.com/company/genedrive-plc/
Bigbench…. £2.58
Jayhayes…. £2.30
Cheemap......£2.76
Scart…. £2.42
liam-vtr.... £1.85
MikeB £2.75
Kenco222 £2.22
Alwaysone ...£2.79
Longrun...... £3
EthioEthio......£2.88
BOTcorp....... £2.55
ThePunter1.....£2.31
Ghia.....£2.38
Dogdays ....£2.62